SCHEMBL376991

SCHEMBL376991

COC1(Cc2ccccc2C)CCC(N2CCN(C(=O)OC(C)(C)C)CC2)CC1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.46
GPR119 Q8TDV5 3/20 0.41
ACACB O00763 1/20 0.41
ACACA Q13085 1/20 0.41
KDM4E B2RXH2 1/20 0.40
PKM P14618 1/20 0.40
OPRM1 P35372 1/20 0.40
OPRD1 P41143 1/20 0.40
OGFRL1 Q5TC84 1/20 0.40
ALDH1A1 P00352 1/20 0.39
CCR3 P51677 1/20 0.39
CHRM2 P08172 1/20 0.39
CHRM4 P08173 1/20 0.39
CHRM1 P11229 1/20 0.39
CHRM3 P20309 1/20 0.39
MAPT P10636 1/20 0.39
STS P08842 1/20 0.38
TGFBR1 P36897 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL376500 0.89 MAPT (0.46) POLBGPR119ACACBACACAKDM4E
SCHEMBL376786 0.89 KDM1A (0.45) GPR119ACACBACACAKDM4EPKM
SCHEMBL376926 0.89 GPR119 (0.48) POLBGPR119ACACBACACAKDM4E
SCHEMBL4818025 0.87 STS (0.47) GPR119ACACBACACAKDM4EPKM
SCHEMBL376616 0.77 LMNA (0.44) POLBCCR3CHRM2CHRM4CHRM1
SCHEMBL8111261 0.76 GPR119 (0.49) POLBGPR119KDM4EOPRD1ALDH1A1
SCHEMBL7842738 0.76 POLB (0.45) POLBGPR119KDM4EPKMOPRD1
SCHEMBL8762096 0.75 OPRD1 (0.44) POLBGPR119KDM4EPKMOPRD1
SCHEMBL377039 0.75 ALDH1A1 (0.47) POLBKDM4EALDH1A1CCR3MAPT
SCHEMBL7842880 0.75 PKM (0.52) POLBKDM4EPKMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1765778-B1 N-SULFONYLCARBOXIMIDAMIDE APOPTOSIS PROMOTERS ABBOTT LAB (US) 2012-01-25 EP disclosed
US-20100035879-A1 N-SULFONYLCARBOXIMIDAMIDE APOPTOSIS PROMOTERS ABBOTT LABORATORIES 2010-02-11 US disclosed
US-20100035879-A1 N-SULFONYLCARBOXIMIDAMIDE APOPTOSIS PROMOTERS ABBOTT LABORATORIES 2010-02-11 US disclosed
US-7585858-B2 N-sulfonylcarboximidamide apoptosis promoters ABBOTT LABORATORIES (US) 2009-09-08 US disclosed
US-20050272744-A1 N-sulfonylcarboximidamide apoptosis promoters ABBVIE INC. 2005-12-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100035879-A1 N-SULFONYLCARBOXIMIDAMIDE APOPTOSIS PROMOTERS BAX, BCL2, BAD POLB 151/4885GPR119 1298/4885ACACB 602/4885
US-20050272744-A1 N-sulfonylcarboximidamide apoptosis promoters BAX, BCL2, BAD POLB 151/4885GPR119 1298/4885ACACB 602/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.